Gene · 2017
Papers4,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Invadopodia in cancer metastasis: dynamics, regulation, and targeted therapies. | J Transl Med | 2025 | 40380267 | PubTator, text mining | PubMed |
| Metabolic reprogramming and immune microenvironment characteristics in laryngeal carcinoma: advances in immunotherapy. | Front Immunol | 2025 | 40370437 | PubTator, text mining | PubMed |
| E-Cadherin Is a Structuring Component of Invadopodia in Pancreatic Cancer. | J Cell Mol Med | 2025 | 40366255 | PubTator, text mining | PubMed |
| CLCa mediates a novel cross-talk between Wnt secretion and actin organization. | Life Sci Alliance | 2025 | 40316417 | PubTator, text mining | PubMed |
| PSTP: accurate residue-level phase separation prediction using protein conformational and language model embeddings. | Brief Bioinform | 2025 | 40315433 | PubTator, text mining | PubMed |
| Integrative proteomic profiling of tumor and plasma extracellular vesicles identifies a diagnostic biomarker panel for colorectal cancer. | Cell Rep Med | 2025 | 40311616 | PubTator, text mining | PubMed |
| Multi-Omics Analysis of Survival-Related Splicing Factors and Identifies CRNKL1 as a Therapeutic Target in Esophageal Cancer. | Genes (Basel) | 2025 | 40282339 | PubTator, text mining | PubMed |
| RAB23 facilitates clathrin-coated nascent vesicle formation at the plasma membrane and modulates cell signaling. | Cell Mol Life Sci | 2025 | 40261407 | PubTator, text mining | PubMed |
| Cellular Signaling at the Nano-Bio Interface: Spotlighting Membrane Curvature. | Annu Rev Phys Chem | 2025 | 40258240 | PubTator, text mining | PubMed |
| A collaborative immunohistochemical study of Drp1 and cortactin in the epithelial dysplasia and oral squamous cell carcinoma. | Diagn Pathol | 2025 | 40217339 | PubTator, text mining | PubMed |
| Protein covariation networks for elucidating ferroptosis inducer mechanisms and potential synergistic drug targets. | Commun Biol | 2025 | 40164758 | PubTator, text mining | PubMed |
| Invadopodia Related-Proteins Expression in Mucoepidermoid Carcinoma. | Oral Dis | 2025 | 40087818 | PubTator, text mining | PubMed |
| Genetic and Molecular Differences in Head and Neck Cancer Based on Smoking History. | JAMA Otolaryngol Head Neck Surg | 2025 | 40048195 | PubTator, text mining | PubMed |
| DCLK1-mediated regulation of invadopodia dynamics and matrix metalloproteinase trafficking drives invasive progression in head and neck squamous cell carcinoma. | Mol Cancer | 2025 | 39994636 | PubTator, text mining | PubMed |
| Retraction notice to Cortactin contributes to the tumorigenesis of gastric cancer by activating ERK/MMP pathway [Heliyon volume 9 2023 e18289]. | Heliyon | 2025 | 39958749 | PubTator, text mining | PubMed |
| DHX9 helicase impacts on splicing decisions by modulating U2 snRNP recruitment in Ewing sarcoma cells. | Nucleic Acids Res | 2025 | 39950342 | PubTator, text mining | PubMed |
| Assessment of Protein Immunoexpression Associated with Tumor Proliferation and Invasion in Histological Subtypes of Unicystic and Conventional Ameloblastoma. | Int J Mol Sci | 2025 | 39941035 | PubTator, text mining | PubMed |
| A Triple-pose Complex Between an Extended WIP Motif and a C-terminal SH3 Domain Modulates Cortactin Activity. | J Mol Biol | 2025 | 39914658 | PubTator, text mining | PubMed |
| Druggable genome CRISPRi screen in 3D hydrogels reveals regulators of cortactin-driven actin remodeling in invading glioblastoma cells. | bioRxiv | 2025 | 39896608 | PubTator, text mining | PubMed |
| AHNAK2: a potential diagnostic biomarker for pancreatic cancer related to cellular motility. | Sci Rep | 2025 | 39849106 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2017/papers?page=6